GlassScriptPhysician profile
Michael Anthony Grecco
NPI 1265524821
$743.56
in general payments reported to CMS, 2019-2025
12 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.00 · 2020: $11.63 · 2022: $147 · 2023: $99.21 · 2024: $209 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $433.28 | 2023-2025 | Ligasure, Truclear |
| Dysis Medical, INC. | $77.68 | 2022 | |
| Astellas Pharma US INC | $39.72 | 2023-2024 | Veozah |
| Scynexis, INC. | $28.38 | 2022 | |
| Sumitomo Pharma America, INC. | $25.42 | 2023 | Myfembree |
| Avion Pharmaceuticals | $23.63 | 2019-2020 | |
| Myovant Sciences INC. | $22.67 | 2022 | |
| Novo Nordisk INC | $21.63 | 2024 | Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $18.64 | 2022 | |
| Meditrina | $18.51 | 2023 | |
| Abbvie INC. | $17.32 | 2023 | |
| Dexcom, INC. | $16.68 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grecco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.